Post by GSK

News for #Investors and #Media Today we announce our strong start to 2026, driven by Specialty Medicines performance, pipeline progress and R&D acceleration. Explore the key highlights ⤵️ Find out more: https://gsk.to/4eOPV5V #Q1Results #Earnings